Novartis Corporation And Alnylam Pharmaceuticals Team Up On Flu Treatment
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Feb. 21, 2006--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), announced today that the company will hold a conference call on Tuesday, February 21, 2006 at 9:00 a.m. ET. During the call, Alnylam will discuss its newly formed collaboration with Novartis to develop an RNAi therapeutic for pandemic flu.